DE4307438A1 - Neue antiviral wirksame Pseudopeptide - Google Patents

Neue antiviral wirksame Pseudopeptide

Info

Publication number
DE4307438A1
DE4307438A1 DE4307438A DE4307438A DE4307438A1 DE 4307438 A1 DE4307438 A1 DE 4307438A1 DE 4307438 A DE4307438 A DE 4307438A DE 4307438 A DE4307438 A DE 4307438A DE 4307438 A1 DE4307438 A1 DE 4307438A1
Authority
DE
Germany
Prior art keywords
carbon atoms
chain
straight
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4307438A
Other languages
German (de)
English (en)
Inventor
Dieter Dr Haebich
Michael Dr Matzke
Klaus Dr Frobel
Thomas Dr Henkel
Hartwig Dr Mueller
Karl-Heinz Dr Weber
Juergen Dr Reefschlaeger
Gert Dr Streissle
Jutta Dr Hansen
Rainer Dr Neumann
Arnold Dr Paessens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE4307438A priority Critical patent/DE4307438A1/de
Priority to AU53147/94A priority patent/AU667995B2/en
Priority to EP94101544A priority patent/EP0611776A3/de
Priority to NZ250863A priority patent/NZ250863A/xx
Priority to IL10862494A priority patent/IL108624A0/xx
Priority to CA002115532A priority patent/CA2115532A1/en
Priority to TW083101199A priority patent/TW261607B/zh
Priority to US08/196,939 priority patent/US5492896A/en
Priority to JP6039254A priority patent/JPH06271600A/ja
Priority to HU9400428A priority patent/HUT67373A/hu
Priority to CN94101549A priority patent/CN1108261A/zh
Publication of DE4307438A1 publication Critical patent/DE4307438A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE4307438A 1993-02-15 1993-03-10 Neue antiviral wirksame Pseudopeptide Withdrawn DE4307438A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE4307438A DE4307438A1 (de) 1993-02-15 1993-03-10 Neue antiviral wirksame Pseudopeptide
AU53147/94A AU667995B2 (en) 1993-02-15 1994-01-12 New pseudopeptides having an antiviral action
EP94101544A EP0611776A3 (de) 1993-02-15 1994-02-02 Neue antiviral wirksame Pseudopeptide.
NZ250863A NZ250863A (en) 1993-02-15 1994-02-11 Pseudopeptides, preparation and antiviral compositions
IL10862494A IL108624A0 (en) 1993-02-15 1994-02-11 Pseudopeptides, their preparation and pharmaceutical compositions containing them
CA002115532A CA2115532A1 (en) 1993-02-15 1994-02-11 Pseudopeptides having an antiviral action
TW083101199A TW261607B (xx) 1993-02-15 1994-02-14
US08/196,939 US5492896A (en) 1993-02-15 1994-02-15 Pseudopeptides having an antiviral action
JP6039254A JPH06271600A (ja) 1993-02-15 1994-02-15 抗ウイルス作用を有するシユードペプチド
HU9400428A HUT67373A (en) 1993-02-15 1994-02-15 Virucide pseudopeptides
CN94101549A CN1108261A (zh) 1993-02-15 1994-02-15 具有抗病毒作用的新的假肽

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4304453 1993-02-15
DE4307438A DE4307438A1 (de) 1993-02-15 1993-03-10 Neue antiviral wirksame Pseudopeptide

Publications (1)

Publication Number Publication Date
DE4307438A1 true DE4307438A1 (de) 1994-08-18

Family

ID=6480445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4307438A Withdrawn DE4307438A1 (de) 1993-02-15 1993-03-10 Neue antiviral wirksame Pseudopeptide

Country Status (3)

Country Link
DE (1) DE4307438A1 (xx)
TW (1) TW261607B (xx)
ZA (1) ZA94986B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030075A1 (de) * 1996-02-16 1997-08-21 Bayer Aktiengesellschaft Antiviral wirksame oxim- und nitronsubstituierte pseudopeptide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030075A1 (de) * 1996-02-16 1997-08-21 Bayer Aktiengesellschaft Antiviral wirksame oxim- und nitronsubstituierte pseudopeptide

Also Published As

Publication number Publication date
ZA94986B (en) 1996-06-26
TW261607B (xx) 1995-11-01

Similar Documents

Publication Publication Date Title
DE69034202T2 (de) Zwischenprodukte zur Herstellung von non-peptiden retroviralproteasehemmenden Verbindungen
DE69400798T2 (de) Urethane und Urea zur Induktion der Cytokin-Produktion
EP0412350A2 (de) Renininhibitoren, Verfahren zur Herstellung und ihre Verwendung in Arzneimitteln
DE4003574A1 (de) Neue dipeptide, verfahren zu ihrer herstellung und ihre verwendung als renininhibitoren in arzneimitteln
DE4331135A1 (de) Neue antiviral wirksame valinhaltige Pseudopeptide
DE3508251A1 (de) Dipeptide
DE4331134A1 (de) Neue antiviral wirksame Pseudopeptide
DE69602940T2 (de) Derivate von bernsteinsäure als protease-inhibitoren
EP0611776A2 (de) Neue antiviral wirksame Pseudopeptide
EP1049666B1 (de) Neue naphthyl- und anilid-substituierte sulfonamide
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
DE4126485A1 (de) Trifluormethyl-haltige pseudopeptide
DE4003575A1 (de) Retroisostere dipeptide, verfahren zur herstellung und ihre verwendung als renininhibitoren in arzneimitteln
EP0437729A2 (de) Neue Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel, insbesondere als Arzneimittel gegen Retroviren
DE4026614A1 (de) Phosphonopyrrolidin- und piperidin-haltige pseudopeptide vom statintyp, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel gegen retroviren
DE4215874A1 (de) Dithiolanylglycinhaltige HIV-Proteaseinhibitoren vom Hydroxyethylenisostertyp
DE4307438A1 (de) Neue antiviral wirksame Pseudopeptide
EP0403828A1 (de) Renininhibitorische Peptide, Verfahren zur ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3615512A1 (de) Prolinderivate
DE3912668A1 (de) Aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0538692A1 (de) Verwendung von teilweise bekannten substituierten Pyrrolidinen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
DE4038921A1 (de) Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1997030075A1 (de) Antiviral wirksame oxim- und nitronsubstituierte pseudopeptide
DE4321502A1 (de) Alkinol-substituierte Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als antiretrovirale Mittel
WO2000061577A1 (de) Prodrugs von thrombininhibitoren

Legal Events

Date Code Title Description
8130 Withdrawal